3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
6
Pain, Postoperative
5
Brain Neoplasms
5
Lung Neoplasms
3
Delirium
3
Uterine Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Kidney Neoplasms
2
Depression
2
Carcinoma, Non-Small-Cell Lung
2
Vomiting
1
Thromboembolism
1
Synovial Cyst
1
Surgical Wound Infection
1
Supratentorial Neoplasms
1
Supratentorial Brain Tumor
1
Stomach Neoplasms
1
Spondylosis
1
Spondylolisthesis
1
Spinal Stenosis
1
Sleep Initiation and Maintenance Disorders
1
Sleep Deprivation
1
Scleroderma, Localized
1
Radiculopathy
1
Prostatic Neoplasms
1
Postoperative Hemorrhage
1
Pituitary Neoplasms
1
Pituitary Diseases
1
Otolaryngeal Cancer
1
Interventions
Escitalopram
2
Venlafaxine Hydrochloride
1
Sugars
1
Saline Solution
1
Interpersonal Psychotherapy
1
Infliximab
1
Bupropion
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Depressive Disorder, Major
×
Saline Solution
×
Clear all
NCT00463580
2025-07-08
Infliximab
Emory University
Phase 4
Completed
60 enrolled
15 charts